Building a Strong Foundation with
Steps involved in the AxiaLIF+ procedure.
Every step of the AxiaLIF+® procedure – Access, Discectomy, Grafting, Distraction, and Stabilization – is designed to produce quality patient outcomes including excellent fusion rates and low complication rates with procedural efficiencies in mind.
Dr. William Tobler talks about the advantages of AxiaLIF+.
About the AxiaLIF+ System
The AxiaLIF+® (Axial Lumbar Interbody Fusion) System is designed to create a safe and reproducible anterior retroperitoneal pre-sacral access route to the L5-S1 vertebral bodies. Recognizing that each patient’s needs are unique, the AxiaLIF+® System represents an outstanding option to address spinal pathology at L5-S1.
The featured instrumentation is designed to enable standard of care fusion principles, distraction, and stabilization of the anterior lumbar column, while mitigating the soft tissue trauma associated with traditional lumbar fusion.
Design Features of AxiaLIF+
Numerous studies have documented the excellent fusion rate and biomechanical stability of AxiaLIF+®. (1,2,3,4) The strength of the implant enables surgeons to build a strong foundation at the base of the spine.
The patented pre-sacral approach AxiaLIF+® causes less patient blood loss, less operating room time, and quick patient recovery.(1,2,3,4) The minimally invasive technique of AxiaLIF+ saves an estimated $3,500 per procedure.5
The internal distraction rod in AxiaLIF+® allows surgeons to individualize distraction in situ based on each patient’s needs. This highly adjustable distraction is achieved as the internal rod is advanced between robust, static anchors.
Shaped for Success
The bone-engagement surfaces on the superior aspect of the implants have a full taper design in which each revolution cuts new, larger threads in the endplate.
Over 85 published research studies support the efficacy, safety and long-term outcomes of AxiaLIF+
1. Bradley WD, Hisey MS, Verma-Kurvari S, Ohnmeiss DD. Minimally invasive trans-sacral approach to L5-S1 interbody fusion: Preliminary results from 1 center and review of the literature. Int J Spine Surg. 2012;6:110-4. PubMed PMID: 25694879; PubMed Central PMCID: PMC4300883. 2. Marchi L, Oliveira L, Coutinho E, Pimenta L. Results and complications after 2-level axial lumbar interbody fusion with a minimum 2-year follow-up. J Neurosurg Spine. 2012 Sep;17(3):187-92. PubMed PMID: 22803626. 3. Tobler WD, Gerszten PC, Bradley WD, Raley TJ, Nasca RJ, et al. Minimally invasive axial presacral L5-S1 interbody fusion: two-year clinical and radiographic outcomes. Spine (Phila Pa 1976). 2011 Sep 15;36(20):E1296-301. PubMed PMID: 21494201. 4. Aryan HE, Newman CB, Gold JJ, Acosta FL Jr, Coover C, Ames CP..2008. Percutaneous axial lumbar interbody fusion (AxiaLIF) of the L5-S1 segment: initial clinical and radiographic experience. Minim Invasive Neurosurg. 51(4):225-30. Pubmed PMID: 18683115
5.Mistry AM, Godil SS, Parker SL, McGirt MJ. Axial presacral lumbar interbody fusion: a systematic literature review. J Manag Care Med. 2014;17(3):47-56.
Indication for use: AxiaLIF System is intended to provide anterior stabilization of the L5-S1 spinal segment (s) as an adjunct to spinal fusion. The system is indicated for patients requiring fusion to treat pseudoarthrosis (unsuccessful previous fusion), spinal stenosis, spondylolisthesis (Grade 1 or 2 if single-level: Grade 1 if two-level), or degeneration disc disease as defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. Its usage is limited to anterior supplemental fixation of the lumbar spine at L5-S1 or L4-S1 in conjunction with use of legally marketed posterior fixation such as facet screw or pedicle screw systems at the same levels that are treated with system.